Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2016 (2016), Article ID 3072135, 6 pages
http://dx.doi.org/10.1155/2016/3072135
Research Article

Cryosurgery as Additional Treatment in Tenosynovial Giant Cell Tumors

Department of Orthopedics, Radboud University Medical Center, Nijmegen, Netherlands

Received 22 August 2016; Revised 1 November 2016; Accepted 4 December 2016

Academic Editor: R. Lor Randall

Copyright © 2016 F. G. M. Verspoor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. W. Myers, A. T. Masi, and S. L. Feigenbaum, “Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review,” Medicine, vol. 59, no. 3, pp. 223–238, 1980. View at Google Scholar · View at Scopus
  2. C. D. M. Fletcher, K. K. Unni, and F. Mertens, Eds., Pathology and Genetics of Tumours of Soft Tissue and Bone, International Agency for Research on Cancer Press, Lyon, France, 2002.
  3. R. B. West, B. P. Rubin, M. A. Miller et al., “A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 3, pp. 690–695, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. F. G. M. Verspoor, I. C. M. van der Geest, E. Vegt, R. P. H. Veth, W. T. van der Graaf, and H. W. B. Schreuder, “Pigmented villonodular synovitis: current concepts about diagnosis and management,” Future Oncology, vol. 9, no. 10, pp. 1515–1531, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Ottaviani, X. Ayral, M. Dougados, and L. Gossec, “Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature,” Seminars in Arthritis and Rheumatism, vol. 40, no. 6, pp. 539–546, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Chiari, C. Pirich, W. Brannath, R. Kotz, and K. Trieb, “What affects the recurrence and clinical outcome of pigmented villonodular synovitis?” Clinical Orthopaedics and Related Research, no. 450, pp. 172–178, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Veth, B. Schreuder, H. van Beem, M. Pruszczynski, and J. de Rooy, “Cryosurgery in aggressive, benign, and low-grade malignant bone tumours,” Lancet Oncology, vol. 6, no. 1, pp. 25–34, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. D. G. Mohler and B. D. Kessler, “Open synovectomy with cryosurgical adjuvant for treatment of diffuse pigmented villonodular synovitis of the knee,” Bulletin: Hospital for Joint Diseases, vol. 59, no. 2, pp. 99–105, 2000. View at Google Scholar · View at Scopus
  9. H. W. B. Schreuder, J. Van Egmond, H. B. H. Van Beem, and R. P. H. Veth, “Monitoring during cryosurgery of bone tumors,” Journal of Surgical Oncology, vol. 65, no. 1, pp. 40–45, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. L. van der Heijden, M. J. L. Mastboom, P. D. S. Dijkstra, and M. A. J. van de Sande, “Functional outcome and quality of life after the surgical treatment for diffuse-type giant-cell tumour around the knee: a retrospective analysis of 30 patients,” Bone and Joint Journal, vol. 96, no. 8, pp. 1111–1118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Bickels, J. Isaakov, Y. Kollender, and I. Meller, “Unacceptable complications following intra-articular injection of yttrium 90 in the ankle joint for diffuse pigmented villonodular synovitis,” Journal of Bone and Joint Surgery—Series A, vol. 90, no. 2, pp. 326–328, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. P. A. Cassier, S. Stacchiotti, H. Gelderblom et al., “Imatinib mesylate for the treatment of locally advanced and/or metastatic pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT),” Journal of Clinical Oncology Conference, vol. 28, 2010. View at Google Scholar
  13. J.-Y. Blay, H. El Sayadi, P. Thiesse, J. Garret, and I. Ray-Coquard, “Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT),” Annals of Oncology, vol. 19, no. 4, pp. 821–822, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. W. M. Snoots, D. Watkins, D. Dockery, R. Mennel, and B. S. Cheek, “Pigmented villonodular synovitis responsive to imatinib therapy,” Baylor University Medical Center Proceedings, vol. 24, pp. 134–138, 2011. View at Google Scholar
  15. E. L. Staals, S. Ferrari, D. M. Donati, and E. Palmerini, “Diffuse-type tenosynovial giant cell tumour: current treatment concepts and future perspectives,” European Journal of Cancer, vol. 63, pp. 34–40, 2016. View at Publisher · View at Google Scholar
  16. L. Vastel, P. Lambert, G. De Pinieux, O. Charrois, M. Kerboull, and J.-P. Courpied, “Surgical treatment of pigmented villonodular synovitis of the hip,” Journal of Bone and Joint Surgery - Series A, vol. 87, no. 5, pp. 1019–1024, 2005. View at Publisher · View at Google Scholar · View at Scopus